Akebia Therapeutics (AKBA) Asset Utilization Ratio (2017 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Asset Utilization Ratio of 0.63 for Q1 2026, down 9.73% year-over-year from 0.7 in Q1 2025, and down 1.39% quarter-over-quarter from 0.64 in Q4 2025.
Akebia Therapeutics (AKBA) Asset Utilization Ratio (2017 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Asset Utilization Ratio for 10 consecutive years, with 0.63 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 9.73% year-over-year to 0.63; the TTM figure through Mar 2026 stood at 0.63 (down 9.73% YoY), while the FY2025 annual figure was 0.79, up 14.16% from the prior year.
- Asset Utilization Ratio retreated to 0.63 in Q1 2026 per AKBA's latest filing, from 0.64 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.85 in Q1 2023 and bottomed at 0.09 in Q1 2022.
- Historically, Asset Utilization Ratio has averaged 0.6 across 5 years, with a median of 0.7 in 2025.
- On a YoY basis, Asset Utilization Ratio climbed as much as 17086.31% in 2022 and fell as far as 133.31% in 2022.
- Akebia Therapeutics' Asset Utilization Ratio stood at 0.58 in 2022, then surged by 41.48% to 0.82 in 2023, then retreated by 8.29% to 0.75 in 2024, then slipped by 14.83% to 0.64 in 2025, then declined by 1.39% to 0.63 in 2026.
- Business Quant data shows AKBA's Asset Utilization Ratio at 0.63 in Q1 2026, 0.64 in Q4 2025, and 0.63 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Akebia Therapeutics | 249.25 Mn | 93.70 Mn | 38.70 Mn | 0.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.62 |
| Mar 31, 2026 | 0.63 |
| Dec 31, 2025 | 0.64 |
| Sep 30, 2025 | 0.63 |
| Jun 30, 2025 | 0.62 |
| Mar 31, 2025 | 0.70 |
| Dec 31, 2024 | 0.75 |
| Sep 30, 2024 | 0.80 |
| Jun 30, 2024 | 0.78 |
| Mar 31, 2024 | 0.80 |
| Dec 31, 2023 | 0.82 |
| Sep 30, 2023 | 0.79 |
| Jun 30, 2023 | 0.75 |
| Mar 31, 2023 | 0.85 |
| Dec 31, 2022 | 0.58 |
| Sep 30, 2022 | 0.05 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | -0.09 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.29 |